BioSpace News Archive

BioMidwest

Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center

Biodesix, Inc. announced that it has entered into a new master collaborative research agreement with Memorial Sloan Kettering Cancer Center under which the teams will collaborate on a development plan for diagnostic tests aimed at improving the treatment of cancer.

March 25, 2024
·
4 min read
Business

Syra Health Announces Fourth-Quarter and Full-Year 2023 Financial Results. Projects 2024 Revenue Growth of 64% to 100%.

Syra Health Corp. today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023.

March 25, 2024
·
11 min read
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit

Alpha Tau Medical Ltd. today announced that CFO Raphi Levy will present a corporate overview and update at the Jefferies Radiopharma Innovation Summit on April 11th , 2024.

March 25, 2024
·
1 min read
Business

Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines

Univercells to test proprietary mRNA vaccine delivered with Altamira’s SemaPhore™ nanoparticles Targeting safer and accessible mRNA vaccines Altamira Therapeutics Ltd.

March 25, 2024
·
7 min read
Drug Development

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

AIM ImmunoTech Inc. today announced the publication of new data analysis from a long-term Early Access Program (“EAP”) studying the company’s drug Ampligen® (rintatolimod) for the treatment of advanced pancreatic ductal adenocarcinoma (“PDAC”).

March 25, 2024
·
4 min read
Drug Development

ProLynx announces initiation of the Phase II Topology clinical trial of its DNA-damaging agent PLX038 in triple-negative breast cancer at the Institut Curie

ProLynx Inc. announced that the first patient was included in TOPOLOGY by investigator Dr. Delphine Loirat, with a Phase II clinical trial investigating PLX038 (PEG~SN-38) for locally-advanced or metastatic triple-negative breast cancer (TNBC).

March 25, 2024
·
2 min read
Business

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates

Biocytogen Pharmaceuticals and ABL Bio Inc. today announced a collaboration to develop new bispecific antibody-drug conjugates (bsADCs).

March 25, 2024
·
4 min read
Policy

Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases

Recent Strategic Partnership and Financing Expected to Fund Operations Through 2026

March 25, 2024
·
10 min read
Business

Gedeon Richter Selects Trial Interactive for Clinical Trial Management

TransPerfect Life Sciences, a leading global provider of solutions for product development and launch for the biopharmaceutical industry, announced that Gedeon Richter selected Trial Interactive’s award-winning eTMF platform and TI Collaborate eClinical solution for its upcoming clinical trials.

March 25, 2024
·
3 min read
Pharm Country

Get Screened: Top Message from Colorectal Cancer Surgeon and Patient

Colorectal cancer is highly preventable with screening. Furthermore, localized colorectal cancer has a 91% five-year survival rate with treatment.i.

March 25, 2024
·
2 min read